(114 days)
No
The description focuses on the mechanical design and function of a balloon catheter for angioplasty, with no mention of AI or ML capabilities. The "Mentions AI, DNN, or ML" section explicitly states "Not Found".
Yes
The device is a Percutaneous Transluminal Angioplasty (PTA) catheter, intended for use in the femoral, iliac, and renal arteries to treat conditions like stenosis, which is a therapeutic intervention. It is used to inflate balloons to open up arteries, which is a direct treatment of a disease.
No
The device is a Percutaneous Transluminal Angioplasty (PTA) catheter, which is used for treatment (dilating arteries), not for diagnosing conditions.
No
The device description clearly describes a physical catheter with balloons, a shaft, and marker bands, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for Percutaneous Transluminal Angioplasty (PTA) in specific arteries (femoral, iliac, and renal). This is a therapeutic procedure performed directly on the patient's body.
- Device Description: The device is a balloon catheter designed to be inserted into blood vessels to dilate them. This is a medical device used for intervention, not for testing samples outside the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used to perform tests in vitro (outside the living organism) on samples from the body. This device is used in vivo (inside the living organism) for a therapeutic purpose.
N/A
Intended Use / Indications for Use
This device is recommended for Percutaneous Transluminal Angioplasty (PTA) of the femoral, iliac and renal arteries. These catheters are not designed to be used in the coronary arteries.
Product codes
NVM
Device Description
The BIB PTA Catheter is This device is recommended for Percutaneous Device Transluminal Angioplasty (PTA) of the femoral, iliac and renal arteries. These catheters are not designed to be used in the coronary arteries. The BIB PTA Catheter has a tri-axial shaft design which allows for inflation of two balloons, one contained inside the other, and a guidewire lumen for placement inside the vasculature. Both balloons are identical to those currently marketed by NuMed on the Tyshak PTA and Z-Med PTA catheters. The balloons are non-compliant and include radiopaque platinum marker bands on the catheter shaft to facilitate placement of the device under fluoroscopy. The BIB catheter will be available in standard diameters from 8 mm to 24 mm for the outer balloon and 4 mm to 12 mm for the inner balloon. Balloon lengths of 1.5 cm to 5.5 cm will available. The device has an overall shaft length of 110 cm. All materials used to manufacture the BIB PTA Balloon Catheter are Biocompatibility available on other commercially available NuMed, Inc. devices (K931009) and have passed all relevant biocompatibility tests. No additional biocompatibility testing was conducted for the BIB PTA Balloon Catheter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
fluoroscopy
Anatomical Site
femoral, iliac and renal arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The BIB PTA Balloon Catheter have been tested and compared to the Summary of predicate devices listed herein. All data gathered demonstrate the BIB PTA Safety and Effectiveness Catheter is substantially equivalent. No new issues of safety or efficacy have been raised.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the text "K050657 p.1 of 2" in a handwritten style. The text is black and appears to be written with a thick marker on a white background. The text is slightly distorted, with the letters appearing uneven and slightly blurred.
Appendix D
510(k) Summary
| General
| Provisions | Trade Name: BIB PTA Balloon Catheter |
|---|---|
| Classification Name: Percutaneous Transluminal Angioplasty Catheter | |
| Name of | |
| Predicate | |
| Device | Tyshak PTA Balloon Catheter (K931009) |
| Z-Med PTA Balloon Catheter (K931009) | |
| Classification | Class II |
| Performance | |
| Standards | Performance Standards have not been established by FDA under Section 514 |
| of the Food, Drug and Cosmetic Act. | |
| Intended Use | This device is recommended for Percutaneous Transluminal Angioplasty |
| (PTA) of the femoral, iliac and renal arteries. These catheters are not | |
| designed to be used in the coronary arteries. | |
| Continued on next page |
1
510(k) 510(k) Summary, Continued
The BIB PTA Catheter is This device is recommended for Percutaneous Device Transluminal Angioplasty (PTA) of the femoral, iliac and renal arteries. Description These catheters are not designed to be used in the coronary arteries. The BIB PTA Catheter has a tri-axial shaft design which allows for inflation of two balloons, one contained inside the other, and a guidewire lumen for placement inside the vasculature. Both balloons are identical to those currently marketed by NuMed on the Tyshak PTA and Z-Med PTA catheters. The balloons are non-compliant and include radiopaque platinum marker bands on the catheter shaft to facilitate placement of the device under fluoroscopy. The BIB catheter will be available in standard diameters from 8 mm to 24 mm for the outer balloon and 4 mm to 12 mm for the inner balloon. Balloon lengths of 1.5 cm to 5.5 cm will available. The device has an overall shaft length of 110 cm. All materials used to manufacture the BIB PTA Balloon Catheter are Biocompatibility available on other commercially available NuMed, Inc. devices (K931009) and have passed all relevant biocompatibility tests. No additional biocompatibility testing was conducted for the BIB PTA Balloon Catheter. The BIB PTA Balloon Catheter have been tested and compared to the Summary of predicate devices listed herein. All data gathered demonstrate the BIB PTA Safety and Effectiveness Catheter is substantially equivalent. No new issues of safety or efficacy have been raised.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features the department's name encircling a symbol. The symbol consists of a stylized caduceus, a staff with two snakes entwined around it, representing medicine and health, along with the letters "USA".
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG - 3 2005
NuMED, Inc. c/o Ms. Nichelle R. LaFlesh Regulatory Affairs Manager 2880 Main St Hopkinton, NY 12965
Re: K050857
BIB PTA Balloon Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II Product Code: NVM Dated: July 1, 2005 Received: July 5, 2005
Dear Ms. LaFlesh:
This letter corrects our substantially equivalent letter of July 28, 2005.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act and the limitations described below. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
The Office of Device Evaluation has determined that there is a reasonable likelihood that this device will be used for an intended use not identified in the proposed labeling and that such use could cause harm. Therefore, in accordance with Section 513(i)(1)(E) of the Act, the following limitation must appear prominently as a boxed warning in the device's labeling immediately following the statement of the Indications for Use:
The safety and effectiveness of this device for use as a stent delivery system in the placement of intravascular stents has not been established.
3
Page 2 - Ms. Nichelle R. LaFlesh
Please note that the above labeling limitations are required by Section 513(i)(1)(E) of the Act. Therefore, a new 510(k) is required before these limitations are modified in any way or removed from the device's labeling.
The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification if the limitation statement described above is added to your labeling.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific information about the application of other labeling requirements to your device (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International, and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Tillman, Ph.D. nna-Bea Director Office of Device Evaluation Center for Devices and Radiological Health
4
Indications for Use
510(k) Number (if known): K050857
Device Name: BIB PTA Balloon Catheter
Indications For Use: This device is labeled for Percutaneous Transluminal Angioplasty (PTA) if the femoral, iliac and renal arteries. These catheters are not designed to be used in the coronary arteries.
Prescription Use_ × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R. Vachner
(Division Sign-Off) (Division Sign-On)
Division of Cardiovascular Devices
510(k) Number K050857